cladribine has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenberger, U; Fleischer, M; Gäckler, A; Hackert, J; Hagenacker, T; Kleinschnitz, C; Krämer, J; Kribben, A; Meuth, SG; Pfeuffer, S; Pfister, F; Pul, R; Ruck, T; Schönfelder, K; Schuh, H; Skuljec, J | 1 |
1 other study(ies) available for cladribine and Bright Disease
| Article | Year |
|---|---|
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment.
Topics: Cladribine; Glomerulonephritis; Humans; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neoplasm Recurrence, Local | 2021 |